Publishing research using ab4833? Please let us know so that we can cite the reference in this datasheet.
ab4833 has been referenced in 4 publications.
Wang H et al.Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.PLoS One 9:e96982 (2014).
Lange K et al.Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment.Cancer Res 68:6942-52 (2008).
Demo SD et al.Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome.Cancer Res 67:6383-91 (2007).
Lange K et al.Endothelin receptor type B counteracts tenascin-C-induced endothelin receptor type A-dependent focal adhesion and actin stress fiber disorganization.Cancer Res 67:6163-73 (2007).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"